Literature DB >> 11874435

Risk of developing diabetes is inversely related to lung function: a population-based cohort study.

G Engström1, L Janzon.   

Abstract

AIM: To investigate whether reduced lung function is a risk factor for developing diabetes.
METHODS: Non-diabetic men (n = 382) from the population-based cohort 'Men Born in 1914' were examined with spirometry at age 55 years. The cohort was re-examined at 68 years. Diabetes and fasting plasma glucose at follow-up were studied in relation to vital capacity (VC) and forced expiratory volume (FEV1.0) at baseline.
RESULTS: Fifteen men developed diabetes during the follow-up. The percentage with diabetes in the 1st, 2nd, 3rd and top quartile of vital capacity were 7%, 5%, 2%, and 1%, respectively (P for trend = 0.01). Fasting glucose (log transformed, mmol/l) at follow-up was 1.63 +/- 0.16, 1.62 +/- 0.18, 1.61 +/- 0.11 and 1.60 +/- 0.11, respectively (P for trend = 0.11). The longitudinal associations between VC and diabetes (P = 0.001) and log glucose (P = 0.036) were significant after adjustments for several potential confounders. FEV(1.0) at baseline showed similar associations with diabetes at follow-up.
CONCLUSIONS: The risk of developing diabetes is inversely associated with pulmonary function among middle-aged men.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11874435     DOI: 10.1046/j.1464-5491.2002.00652.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  36 in total

1.  Vital capacity and selected metabolic diseases in middle-aged Japanese men.

Authors:  H Sakuta; Takashi Suzuki; Hiroko Yyasuda; Teizo Ito
Journal:  Can Respir J       Date:  2006-03       Impact factor: 2.409

2.  Association of asthma and hay fever with irregular menstruation.

Authors:  C Svanes; F Gomez Real; T Gislason; C Jansson; R Jögi; E Norrman; L Nyström; K Torén; E Omenaas
Journal:  Thorax       Date:  2005-06       Impact factor: 9.139

Review 3.  The diabetic lung--a new target organ?

Authors:  Dario Pitocco; Leonello Fuso; Emanuele G Conte; Francesco Zaccardi; Carola Condoluci; Giuseppe Scavone; Raffaele A Incalzi; Giovanni Ghirlanda
Journal:  Rev Diabet Stud       Date:  2012-05-10

Review 4.  The bidirectional relationship between chronic obstructive pulmonary disease and coronary artery disease.

Authors:  Ayham Daher; Michael Dreher
Journal:  Herz       Date:  2020-04       Impact factor: 1.443

5.  Uncovering Metabolic Syndrome among Chronic Obstructive Pulmonary Disease Patients in a Tertiary Care Hospital, India.

Authors:  Kamlesh Kumar Gupta; Jitendra Singh; Pradeep Gupta; M L Patel; Vivek Kumar; Shyam Chand Chaudhary
Journal:  J Clin Diagn Res       Date:  2017-05-01

Review 6.  Comorbidities in chronic obstructive pulmonary disease.

Authors:  Wissam M Chatila; Byron M Thomashow; Omar A Minai; Gerard J Criner; Barry J Make
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

7.  A cross-sectional relationship between vital capacity and metabolic syndrome and between vital capacity and diabetes in a sample Japanese population.

Authors:  Eiji Oda; Ryu Kawai
Journal:  Environ Health Prev Med       Date:  2009-07-22       Impact factor: 3.674

8.  Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women's Heart and Health Study.

Authors:  D A Lawlor; S Ebrahim; G Davey Smith
Journal:  Diabetologia       Date:  2003-12-24       Impact factor: 10.122

9.  Low lung function and risk of type 2 diabetes in Japanese men: the Toranomon Hospital Health Management Center Study 9 (TOPICS 9).

Authors:  Yoriko Heianza; Yasuji Arase; Hiroshi Tsuji; Kazumi Saito; Kazuhisa Amakawa; Shiun Dong Hsieh; Satoru Kodama; Hitoshi Shimano; Nobuhiro Yamada; Shigeko Hara; Hirohito Sone
Journal:  Mayo Clin Proc       Date:  2012-09       Impact factor: 7.616

10.  Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Hsin-Chieh Yeh; Naresh M Punjabi; Nae-Yuh Wang; James S Pankow; Bruce B Duncan; Christopher E Cox; Elizabeth Selvin; Frederick L Brancati
Journal:  Diabetes Care       Date:  2007-12-04       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.